Form 4: Baxter International Director Nancy M. Schlichting Reports Acquisition of Shares

Director Nancy M. Schlichting reports the acquisition of 5,952 shares of Baxter International common stock on May 7, 2024.

Summary

• On May 7, 2024, Nancy M. Schlichting, a director of Baxter International Inc., acquired 5,952 shares of common stock.
• The shares were acquired at a price of $0.
• Following the transaction, Schlichting beneficially owns 14,278 shares of Baxter International Inc.
• The filing also includes a Power of Attorney, effective February 12, 2024, authorizing David S. Rosenbloom, Ellen K. Bradford, and Kimberly Olson to act on Schlichting's behalf for SEC filings related to Baxter securities.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard regulatory filing detailing a stock transaction. The acquisition of shares by a director is generally viewed as a positive sign, but the document itself is purely informational.

Positives

• The acquisition of shares by a director can be seen as a positive signal, indicating confidence in the company's future.

Future Outlook

The document does not contain any specific forward-looking statements or guidance.

Industry Context

This filing is a routine disclosure related to insider transactions, which are common in publicly traded companies. It provides transparency regarding the holdings and transactions of company insiders.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies, ensuring transparency of insider transactions.
• Similar filings are made by directors and officers of companies like Johnson & Johnson, Medtronic, and Abbott Laboratories when they buy or sell shares of their respective companies.

Stakeholder Impact

• The acquisition of shares by a director can have a minor positive impact on shareholder sentiment.

Key Dates